Premier Perspectives The blog for insider insights in clinical development Clinical Research: Phase 1 - Phase 4 7 Factors Fueling the Growth of Oncology Trials in Asia-Pacific By Ashish Jain August 15, 2022 Featured Posts Clinical ResearchPhase 1 - Phase 4 Conducting Successful Oncology Trials in the Asia-Pacific Region By Ashish Jain August 8, 2022 Consulting Reimbursement Rules & Considerations for Medical Device Development in Asia By Ashish Jain January 8, 2020 Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting 4 APAC Countries With Shifting Medical Device Regulations: What You Need to Know By Ashish Jain December 4, 2019 Clinical ResearchPhase 1 - Phase 4 Untapped Potential: Asia-Pacific’s Growing Role in Biotech Drug Research By Ashish Jain March 20, 2019 Medical and Regulatory Affairs 5 Reasons to Consider APAC for Clinical Trials By Ashish Jain October 17, 2018 Clinical ResearchPhase 1 - Phase 4 Conducting Clinical Trials in the Asia Pacific Region: Opportunities and Obstacles By Ashish Jain October 8, 2018 × ALSO OF INTERESTKey Considerations When Designing a Phase 1...7 Questions About Clinical Evaluations for MDRNostalgia or Shell Shock? Assessing PTSD Is a...
